← Leaderboards
Lucy Q Shen
Schepens Eye Research Institute
$1,443,022
Attributed
$4,329,067
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,329,067 · 1
By mechanism
R01$4,329,067 · 1
Top collaborators
- Dong Feng Chen8 shared
- Jianzhu Chen8 shared
Most similar at Schepens Eye Research Institute
Same institution · by research overlap
- Dong Feng Chen$10,365,160
- Daniel Sun$3,021,750
- Mengyu Wang$2,926,473
- Ann Marshak-Rothstein$30,359,235
- Lu Chen$7,427,986
Others in their field
Other Emerging Leaders on “Peripheral Blood”
- Thomas Denny · Duke University$29,111,395
- James Dale Berry · Brigham And Women'S Hospital$19,493,214
- Maria C Carrillo · Indiana University Indianapolis$19,445,642
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$14,520,572
- Niccolo Terrando · Duke University$9,559,615
- Jennifer Cohen Price · University Of California, San Francisco$9,197,178
Research focus
Peripheral BloodT-LymphocyteImmunePathogenesisRetinaT Cell ResponseHeat Shock ProteinsBrainNatural ImmunityNeuronsAdaptive ImmunityPhysiologic Intraocular PressureSignal TransductionStressCd4 Positive T LymphocytesGlaucomaAffectAxonMolecularMouse ModelCellsNerve DegenerationBiological MarkersCollaborations
Grant awards (8)
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$610,152
R01 · FY2025 · EY
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$717,827
R01 · FY2024 · EY
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$140,834
R01 · FY2024 · EY
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$717,827
R01 · FY2023 · EY
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$504,370
R01 · FY2023 · EY
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$696,292
R01 · FY2022 · EY
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$181,348
R01 · FY2022 · EY
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma$760,417
R01 · FY2021 · EY